News | March 14, 2024
Cureskin secures US$ 20 million in Series B funding
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
The company is making its entry into the Hyderabad market through its unique asset-light business model
The funding round also saw participation from some of India's top angel investors and leading industry giants
The funding will enable the company to expand into the segment of HealthCare Service offerings, both in terms of geography and operations
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Subscribe To Our Newsletter & Stay Updated
